Equillium EQ
NASDAQ EQ
$2.21 -0.01 (-0.45%)
At close: Sep 4, 2026 · 4:00 PM EDT

Equillium (EQ) Net Cash Flow (2018 - 2026)

Equillium (EQ) posted quarterly Net Cash Flow of $31.0 million for Q1 2026, up 966.61% year-over-year from $2.9 million in Q1 2025, and up 1177.1% quarter-over-quarter from -$2.9 million in Q4 2025.

Analysis

Equillium (EQ) Net Cash Flow (2018 - 2026) Analysis & Trends

Equillium (EQ) has reported Net Cash Flow for 9 consecutive years, with $31.0 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Net Cash Flow rose 966.61% year-over-year to $31.0 million; the TTM figure through Mar 2026 stood at $46.8 million (up 1507.18% YoY), while the FY2025 annual figure was $12.1 million, up 340.59% from the prior year.
  • Net Cash Flow improved to $31.0 million in Q1 2026 per EQ's latest filing, from -$2.9 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $33.3 million in Q4 2022 and bottomed at -$34.6 million in Q1 2023.
  • Historically, Net Cash Flow has averaged $639411.8 across 5 years, with a median of -$621000.0 in 2024.
  • Annual changes were most pronounced in 2025 — Net Cash Flow sank 387.76% — and 2026, when it jumped 966.61%.
  • Equillium's Net Cash Flow stood at $33.3 million in 2022, then slumped by 133.44% to -$11.2 million in 2023, then jumped by 124.84% to $2.8 million in 2024, then slumped by 204.04% to -$2.9 million in 2025, then surged by 1177.1% to $31.0 million in 2026.
  • Business Quant data shows EQ's Net Cash Flow at $31.0 million in Q1 2026, -$2.9 million in Q4 2025, and $21.6 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 652.90 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -504.30 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -183.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 374.50 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 407.41 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -496,000.00
8 Royalty Pharma 28.45 Bn 27.61 Bn - 225.59 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -37.14 Mn
10 Equillium 249.33 Mn 249.33 Mn - -4.14 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -4.14 Mn
Mar 31, 2026 31.04 Mn
Dec 31, 2025 -2.88 Mn
Sep 30, 2025 21.64 Mn
Jun 30, 2025 -3.03 Mn
Mar 31, 2025 -3.58 Mn
Dec 31, 2024 2.77 Mn
Sep 30, 2024 4.34 Mn
Jun 30, 2024 -621,000.00
Mar 31, 2024 -11.63 Mn
Dec 31, 2023 -11.15 Mn
Sep 30, 2023 8.82 Mn
Jun 30, 2023 1.17 Mn
Mar 31, 2023 -34.61 Mn
Dec 31, 2022 33.35 Mn
Sep 30, 2022 1.94 Mn
Jun 30, 2022 -2.57 Mn
Mar 31, 2022 -24.12 Mn
Dec 31, 2021 -26.80 Mn
Sep 30, 2021 3.63 Mn